Mpox clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Tecovirimat for Human Mpox Virus
Sorry, in progress, not accepting new patients
A5418 is a randomized, placebo-controlled, double-blind study to establish the efficacy of tecovirimat for the treatment of people with laboratory-confirmed or presumptive HMPXV disease.
Los Angeles 5368361, California 5332921 and other locations
Last updated: